Westminster, CA – September 26, 2019 – BioLargo, Inc.
(OTCQB:BLGO), developer of sustainable technologies and a full-service
environmental engineering company, today announced that it has signed a
Memorandum of Understanding (MOU) with BKT Co. Ltd (and its US subsidiary Tomorrow Water), and the City of Daegu,
South Korea. The MOU represents the formation of a strategic alliance aimed at exploring
opportunities for BioLargo’s technologies in the water and wastewater industry
of South Korea. The MOU calls for an initial focus by the group on seeking clients
to utilize BioLargo’s disruptive odor and VOC control product, CupriDyne®
Clean, in South Korea’s wastewater treatment industry.
BKT Co. Ltd (www.bkt21.com)
is a major wastewater treatment solutions provider in South Korea and Vietnam
which prides itself in developing and adopting innovative, environmentally
friendly technologies and practices. The City of Daegu, nicknamed South Korea’s
Hub of Creative Economy, is developing a regional water innovation cluster
aimed at fostering the development and deployment of novel, disruptive
technologies into South Korea and Asia’s water industry, intending to create a
future “global hub” for water industries. Daegu’s mayor, Kwon Young-jin, was
present to sign the MOU at the signing ceremony, which took place at WEFTEC
2019.
President of BioLargo’s Odor-No-More subsidiary Joseph
Provenzano commented, “We hold BKT in the highest esteem. It is a technological
innovator and is well-regarded for its leadership in water and wastewater
science. This strategic alliance is a result of our successful trials managing
odors in hog production and livestock wastewater facilities, BKT’s testing of
our product at their Korean facilities, and their recognition of the potential for
CupriDyne® Clean to solve odor and VOC control challenges in an affordable,
environmentally friendly way.”
BioLargo President & CEO Dennis P. Calvert commented, “Although
South Korea and Asia is an enormous opportunity for our technology, we want to
be very careful with whom we choose to partner in that market. BKT has an
unparalleled reputation in Korea and the confidence of the City of Daegu.”
The CEO of Tomorrow Water (www.tomorrowwater.com), Dong Woo Kim,
commented, “It is our pleasure to introduce a safe and environmentally friendly
odor control product into the Korean market. We believe this will lead to other
big Asian markets, and by leveraging the communication channel and network that
the City of Daegu has, this will be a very possible scenario. There is also the
potential for us to introduce BioLargo’s AOS (Advanced Oxidation System) into Korea’s
wastewater treatment industry by utilizing the experience and network that BKT
has. We see lots of collaboration potential between the two entities."
Pictures and video from the MOU signing ceremony:
About Tomorrow Water and BKT
Tomorrow Water is a solutions provider for water and energy.
We are founded on the framework that we can minimize the environmental impact of wastewater treatment through sustainable and profitable processes.
Our strength lies in our diverse portfolio of technologies and our people. With our dedicated team of researchers and engineers, we’re able to overcome the challenges faced in wastewater treatment, while maximizing economic benefits by promoting local tourism, decreasing energy costs, and generating direct income sources in the form of carbon credits and advanced energy production.
We are committed to solving the world’s challenges of today, while designing comprehensive solutions for the needs of tomorrow. We offer comprehensive consulting, engineering, operating, and financing services and solutions for each and every client.
Link to BKT and Tomorrow Water Corporate Presentation
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and
environmental engineering company driven by a mission to "make life
better" by delivering robust, sustainable solutions for a broad range of
industries and applications, with a focus on clean water, clean air, and
advanced wound care. We develop and commercialize disruptive technologies by
providing the capital, support, and expertise to expedite them from
"cradle" to "maturity" (www.biolargo.com).
Our engineering division features experienced professional engineers dedicated
to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne
Clean Industrial Odor Eliminator (www.cupridyne.com),
which eliminates the odor-causing compounds and VOCs rather than masking them,
and is now winning over leading companies in the solid waste handling and
wastewater industries and other industries that contend with malodors and VOCs.
Our subsidiary BioLargo Water (www.biolargowater.ca)
develops the Advanced Oxidation System "AOS," a disruptive industrial
water treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective
and gentle solutions for chronic infected wounds to promote infection control
and regenerative tissue therapy.
Contact Information
Dennis Calvert President and CEO BioLargo, Inc. Dennis.Calvert@BioLargo.com
Safe Harbor Act
This press release includes “forward-looking statements”
within the meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Actual results may differ from
expectations, estimates and projections and, consequently, you should not rely
on these forward-looking statements as predictions of future events. Words such
as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,”
“intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,”
“potential,” “continue,” and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements involve
significant risks and uncertainties that could cause the actual results to
differ materially from the expected results.
No comments:
Post a Comment